Welcome to the website of the European Health Data & Evidence Network (EHDEN), an IMI 2 consortium with 22 partners which will operate in Europe for the coming five years, 2018 – 2024.

EHDEN was launched to address the current challenges in generating insights and evidence from real-world clinical data at scale, to support patients, clinicians, payers, regulators, governments, and the pharmaceutical industry in understanding wellbeing, disease, treatments, outcomes and new therapeutics and devices.



Second high-impact paper published based on the results of OHDSI’s LEGEND study!

According to a recent OHDSI paper, chlorthalidone, the guideline-recommended diuretic for lowering blood pressure,...

Read More
The EHDEN Consortium launches a second open call for SMEs.

The ambitions of the EHDEN project are high. We aim to standardise more than...

Read More
European Medicines Agency is an important partner in generating real world evidence.

Europe’s lead regulatory authority is very active in working with real work data (RWD)...

Read More
The 2nd EHDEN & OHDSI Studyathon on Rheumatoid Arthritis

Between January 13 and 17, approximately 40 people of all disciplines, from clinical to...

Read More

Posts Navigation



March 2020
June 2020
October 2020
No event found!